SHWACHMAN DIAMOND SYNDROME UK
To support patients and families in the UK affected by Shwachman-Diamond Syndrome (SDS) by: promoting access to health and educational services for affected patients throughout the UK, supporting research into the pathophysiology of SDS and its current and potential treatment, and providing educational resources and activities about SDS for the benefit of families, professionals and the public.
Financial health, per its FY2025 accounts
The accounts state that the charity generated a net surplus of £30,981 for the year ended 31 October 2025, with total income of £56,700 against expenditure of £25,719. Per the trustees' report, unrestricted reserves stood at £126,944, while the charity retained £9,500 as a buffer against funding fluctuations. The trustees maintain modest reserves to ensure continuity of operations and cover essential costs for at least three months of activity.
What the accounts disclose
“The trustees maintain modest reserves to ensure continuity of operations and to cover essential costs for at least three months of activity.” — page 4
Trustees
- Andrew Oldingchair
- Kapil Gotecha
- Rebecca Cuffe
Income and spending
| Financial year end | Income | Spending |
|---|---|---|
| 31/10/2025 | £57k | £26k |
| 31/10/2024 | £55k | £66k |
| 31/10/2023 | £62k | £12k |
| 31/10/2022 | £8k | £0 |
| 31/10/2021 | £29k | £15k |
Common questions
Is SHWACHMAN DIAMOND SYNDROME UK financially healthy?
Per its FY2025 accounts: The accounts state that the charity generated a net surplus of £30,981 for the year ended 31 October 2025, with total income of £56,700 against expenditure of £25,719. Per the trustees' report, unrestricted reserves stood at £126,944, while the charity retained £9,500 as a buffer against funding fluctuations. The trustees maintain modest reserves to ensure continuity of operations and cover essential costs for at least three months of activity. Its FY2025 accounts were independently examined.